In contrast to the cell line findings, we found no correlation between the induction of apoptosis by FT538 iPSC‐NKs and the primary AML cells' mutation profiles (including FLT3 and TP53 mutations). The gene discussed is FLT3; the disease is acute myeloid leukemia.